Stock Scorecard
Stock Summary for Capricor Therapeutics Inc (CAPR) - $7.47 as of 10/13/2026 5:56:16 PM EST
Total Score
9 out of 30
Safety Score
34 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for CAPR
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CAPR
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CAPR
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for CAPR
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for CAPR (34 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 3 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for CAPR
Financial Details for CAPR
Company Overview |
|
|---|---|
| Ticker | CAPR |
| Company Name | Capricor Therapeutics Inc |
| Country | USA |
| Description | Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapies for the treatment and prevention of a broad spectrum of diseases. The company is headquartered in Beverly Hills, California. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 6/30/2026 |
| Next Earnings Date | 11/9/2026 |
Stock Price History |
|
| Last Day Price | 7.47 |
| Price 4 Years Ago | 3.86 |
| Last Day Price Updated | 10/13/2026 5:56:16 PM EST |
| Last Day Volume | 1,460,327 |
| Average Daily Volume | 3,807,501 |
| 52-Week High | 40.37 |
| 52-Week Low | 2.96 |
| Last Price to 52 Week Low | 152.36% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 25.08 |
| Sector PE | 60.28 |
| 5-Year Average PE | -8.10 |
| Free Cash Flow Ratio | 20.75 |
| Industry Free Cash Flow Ratio | 10.24 |
| Sector Free Cash Flow Ratio | 34.28 |
| Current Ratio Most Recent Quarter | 7.35 |
| Total Cash Per Share | 0.36 |
| Book Value Per Share Most Recent Quarter | 4.24 |
| Price to Book Ratio | 2.21 |
| Industry Price to Book Ratio | 3.73 |
| Sector Price to Book Ratio | 28.88 |
| Price to Sales Ratio Twelve Trailing Months | 25.15 |
| Industry Price to Sales Ratio Twelve Trailing Months | 30.51 |
| Sector Price to Sales Ratio Twelve Trailing Months | 26.78 |
| Analyst Buy Ratings | 3 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 58,139,000 |
| Market Capitalization | 434,298,330 |
| Institutional Ownership | 76.29% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -159.58% |
| Reported EPS 12 Trailing Months | -2.45 |
| Reported EPS Past Year | -1.29 |
| Reported EPS Prior Year | -2.26 |
| Net Income Twelve Trailing Months | -129,416,560 |
| Net Income Past Year | -105,043,946 |
| Net Income Prior Year | -40,467,186 |
| Quarterly Revenue Growth YOY | -7.90% |
| 5-Year Revenue Growth | -100.00% |
| Operating Margin Twelve Trailing Months | 0.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 20,935,187 |
| Total Cash Past Year | 287,847,312 |
| Total Cash Prior Year | 11,286,996 |
| Net Cash Position Most Recent Quarter | 17,558,928 |
| Net Cash Position Past Year | 284,471,053 |
| Long Term Debt Past Year | 3,376,259 |
| Long Term Debt Prior Year | 3,376,259 |
| Total Debt Most Recent Quarter | 3,376,259 |
| Equity to Debt Ratio Past Year | 0.99 |
| Equity to Debt Ratio Most Recent Quarter | 0.99 |
| Total Stockholder Equity Past Year | 305,792,145 |
| Total Stockholder Equity Prior Year | 145,462,336 |
| Total Stockholder Equity Most Recent Quarter | 246,218,890 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -129,778,200 |
| Free Cash Flow Per Share Twelve Trailing Months | -2.23 |
| Free Cash Flow Past Year | -72,715,722 |
| Free Cash Flow Prior Year | -41,534,717 |
Options |
|
| Put/Call Ratio | 2.22 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -2.17 |
| MACD Signal | -1.99 |
| 20-Day Bollinger Lower Band | 19.54 |
| 20-Day Bollinger Middle Band | 28.10 |
| 20-Day Bollinger Upper Band | 36.66 |
| Beta | 0.61 |
| RSI | 27.18 |
| 50-Day SMA | 20.46 |
| 150-Day SMA | 12.49 |
| 200-Day SMA | 10.55 |
System |
|
| Modified | 10/12/2026 7:43:57 PM EST |